Hendricks Regional Health CEO named to lead Ascension St. Vincent
Kevin Speer, who is to replace Jonathan Nalli, will take over as health system is going through a major restructuring.
John Russell
Articles
Indiana sizing up possible bid for new federal life-sciences hubs
The Advanced Research Projects Agency for Health, or ARPA-H, is looking for cities that can help design biomedical products, enhance clinical trials and bring new health products to market. Winning bidders would land hundreds of jobs.
Life sciences industry booster BioCrossroads girds for new challenges
Patricia Martin, the group’s president and CEO since 2019, last month announced she would step down to examine opportunities in the private sector and urged industry leaders to take a fresh look at the organization.
Ascension St. Vincent CEO Nalli leaving health system in April
Ascension, the largest health system in central Indiana by number of beds, did not name a successor. It said in the announcement it “will be working through a thoughtful transition plan.”
Holcomb signs controversial utility bill into law
The new law could allow utilities to pass along certain costs to customers for federally mandated projects without having to get pre-approval for those projects from state regulators.
Elanco’s shares slip to all-time low after Moody’s downgrade
Moody’s action pushed Elanco’s credit rating further into “junk bond” territory, an area considered riskier than investment-grade debt.
State medical institute lands $38M grant from feds
The National Institutes of Health awarded the grant to the Indiana Clinical and Translational Sciences Institute, a partnership among Indiana University, Purdue University and University of Notre Dame.
IU med school shuts down research project that used expired supplies on pigs
Fred Cate, IU’s vice president for research, informed federal officials that the research group had “a pattern of non-compliance” and had been warned several times against using expired materials.
Fishers startup lands another $1.25M to help launch anti-clotting device
Recovery Force Health said it plans to use the new funding as growth capital to market its device to hospitals and introduce other products.
Money debate begins in Statehouse over transition to green energy
A bill advancing through the Legislature would add natural gas to the list of clean-energy projects state utility regulators could consider for a financial incentive known as “construction work in progress,” or CWIP for short.
Lilly’s older Alzheimer’s drug fails to prevent disease in trial
Eli Lilly said the study concludes its clinical development of solanezumab, apparently shutting the door on one of the most closely watched experimental drugs over the past decade.
In ninth try, Eli Lilly asks shareholders to end staggered terms for board members
The Weinberg Center for Corporate Governance at the University of Delaware, a leading voice for responsible corporate leadership, has generally supported the elimination of staggered terms, saying they can lead to entrenched boards and management that fails to perform.
Investors wary as Elanco pins hopes on new products
Shares in the animal health care company have lost more than two-thirds of their value in the past 18 months, but Elanco says a bevy of new products in its pipeline will prove an era of strong growth is yet to come.
Under growing pressure, Lilly to cut price of popular insulins by 70%
The Indianapolis-based drugmaker also said it will expand a program that caps patient out-of-pocket costs at $35 or less a month.
IU School of Medicine lands $215M in NIH funding, just shy of another record
Five of the top 10 research studies that received the most NIH funding at the medical school were for Alzheimer’s disease or brain aging, one of the school’s top priorities.
IU Health’s operating income falls 25%, squeezed by labor shortage, rising expenses
IU Health said it responded to its highest patient demand ever last year, driven by surges in COVID-19 cases, high counts of critically ill patients, and the need to perform surgeries and other procedures delayed in the pandemic.
Elanco shares fall 12% on disappointing revenue outlook
The Greenfield-based maker of animal medicines said fourth-quarter revenue fell due to “environmental and competitive pressure” and could continue to slip this year.
After 3 years and 500 court filings, Community Health and feds still wrangling over false-claims allegations
In January 2020, the federal government filed a lawsuit against Community Health Network, alleging the system engaged in a years-long scheme to recruit physicians and pay them huge salaries and bonuses in return for referrals. The two sides are still battling in court.
Tale of two downtowns: $9B set to be invested in projects, even as business district struggles with recovery
Many parts of downtown are thriving—particularly neighborhoods, where rents are rising, people have to stand in line for a lunch table, and investments are flowing. Other parts—especially downtown’s central core, where many workers might come to the office only once or twice a week—are limping along, pockmarked by vacant storefronts, panhandlers and crumbling sidewalks.
Downtown’s largest employers bet on hybrid work
Cummins, Rolls-Royce, Eli Lilly and Co., AES and Elevance Health are among the city’s largest downtown employers and all say most of their workers have the option of working at home at least part of the time.